EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Brain Permeable SGK1 Inhibitors: A Promising Therapeutic Strategy for Neurodegenerative Diseases

Enrique Madruga iD, Alfonso Garcia-Rubia, Carlos Sanchez-Nuñez, Loreto Martinez-Gonzalez, Ana María Fernandez-Escamilla, Isabel Lastres-Becker, Carmen Gil iD, Ana Martinez iD

Journal of Medicinal Chemistry · 26.03.2026 · 69 (6) · 6790-6815

DOI: 10.1021/acs.jmedchem.5c03050 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 16.03.2026. Verfasst von Enrique Madruga und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Investigaciones Biológicas "Margarita Salas"─CSIC, Ramiro de Maeztu 9, 28040 Madrid, Spain. Hauptthemen laut MEDLINE: Protein Serine-Threonine Kinases, Immediate-Early Proteins, Protein Kinase Inhibitors, Neurodegenerative Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Generalitat Valenciana, Ministerio de Universidades, Ministerio de Ciencia, Innovaci?n y Universidades.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Serine-Threonine KinasesImmediate-Early ProteinsProtein Kinase InhibitorsNeurodegenerative DiseasesBrainSerum-Glucocorticoid Regulated KinasesHumansAnimalsBlood-Brain BarrierStructure-Activity Relationship

Substanzen

Serum-Glucocorticoid Regulated KinasesProtein Serine-Threonine KinasesImmediate-Early ProteinsProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Centro de Investigaciones Biológicas "Margarita Salas"─CSIC, Ramiro de Maeztu 9, 28040 Madrid, Spain.
  • Centro de Investigación Biomédica en Red en Enfermedades Neurodegeneartivas (CIBERNED), Instituto de Salud Carlos III, 28029 Madrid, Spain.
  • Instituto de Investigación, Desarrollo e Innovación en Biotecnología Sanitaria de Elche (IDiBE), Universitas Miguel Hernández, 03202 Elche, Alicante, Spain.
  • Instituto de Investigaciones Biomédica "Sols-Morreale"─CSIC/UAM, Arturo Duperier 4, 28039 Madrid, Spain.
  • Instituto de Investigación Sanitaria La Paz (IdiPaz), Paseo de la Castellana, 261, 28046 Madrid, Spain.

ORCID-Profile: Enrique Madruga, Carmen Gil, Ana Martinez

Förderung

  • Generalitat Valenciana
  • Ministerio de Universidades
  • Ministerio de Ciencia, Innovaci?n y Universidades
  • Centro de Investigaci?n Biom?dica en Red sobre Enfermedades Neurodegenerativas
  • International Center for Aging Research

Zitieren

APA

Madruga, E., Garcia-Rubia, A., Sanchez-Nuñez, C., Martinez-Gonzalez, L., Fernandez-Escamilla, A. M., Lastres-Becker, I., Gil, C., & Martinez, A. (2026). Brain Permeable SGK1 Inhibitors: A Promising Therapeutic Strategy for Neurodegenerative Diseases. Journal of Medicinal Chemistry, 69(6), 6790-6815. https://doi.org/10.1021/acs.jmedchem.5c03050

Vancouver

Madruga E, Garcia-Rubia A, Sanchez-Nuñez C, Martinez-Gonzalez L, Fernandez-Escamilla AM, Lastres-Becker I, et al. Brain Permeable SGK1 Inhibitors: A Promising Therapeutic Strategy for Neurodegenerative Diseases. Journal of Medicinal Chemistry. 2026;69(6):6790-6815. doi:10.1021/acs.jmedchem.5c03050

BibTeX
@article{Madruga2026,
  author = {Madruga, Enrique and Garcia-Rubia, Alfonso and Sanchez-Nuñez, Carlos and Martinez-Gonzalez, Loreto and Fernandez-Escamilla, Ana María and Lastres-Becker, Isabel and Gil, Carmen and Martinez, Ana},
  title = {Brain Permeable SGK1 Inhibitors: A Promising Therapeutic Strategy for Neurodegenerative Diseases},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  volume = {69},
  number = {6},
  pages = {6790--6815},
  doi = {10.1021/acs.jmedchem.5c03050}
}
Kostenlos starten →